Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Cash Flow from Operations

Rigel Pharmaceuticals Cash Flow from Operations Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Rigel Pharmaceuticals Cash Flow from Operations for the quarter ending June 06, 2020 was $-14m a -4.30% increase of 1m year over year
  • Rigel Pharmaceuticals Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-41m a 51.19% decrease of -21m year over year
  • Rigel Pharmaceuticals Annual Cash Flow from Operations for 2019 was $-42m a -41.72% increase of 17m from 2018
  • Rigel Pharmaceuticals Annual Cash Flow from Operations for 2018 was $-59m a -31.84% increase of 19m from 2017
  • Rigel Pharmaceuticals Annual Cash Flow from Operations for 2017 was $-78m a 2.15% decrease of -2m from 2016
Other Cash Flow Metrics:
  • Rigel Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $1m a 1,495.75% increase of 15m year over year
  • Rigel Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $5m a 26.33% increase of 1m year over year
View Chart On Koyfin

Quarterly RIGL Cash Flow from Operations Data

06/2020$-14m
03/2020$-3m
12/2019$-10m
09/2019$-15m
06/2019$-17m
03/2019$-1m
12/2018$12m
09/2018$-20m
06/2018$-27m
03/2018$-23m

Annual RIGL Cash Flow from Operations Data

2019$-42m
2018$-59m
2017$-78m
2016$-76m
2015$-23m
2014$-70m
2013$-86m
2012$-85m
2011$-69m
2010$47m